Neuronal intranuclear inclusion disease with cortical involvement in left hemisphere: a case report
Wiener klinische Wochenschrift · 2024
DOI: 10.1007/s00508-023-02232-1 ↗Kurz gefasst
Fallbericht in der Zeitschrift Wiener klinische Wochenschrift, 2024. Verfasst von Xiao-Ju Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, First Affiliated Hospital of Guangxi Medical University, 530021, Nanning, China. Hauptthemen laut MEDLINE: Neurodegenerative Diseases. Die Arbeit nennt 21 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Province, Guangxi Medical and Health Appropriate Technology Development and Application Project.
Abstract (Originalsprache)
BACKGROUND: Neuronal intranuclear inclusion disease (NIID) is a rare highly heterogeneous disease. In this paper, we present a case of NIID featured in cortical involvement in left hemisphere of brain and the imaging changes in the process of the disease. CASE PRESENTATION: A 57-year-old female was hospitalized due to recurrent attacks of headache with cognitive impairment and tremor for 2 years. The symptoms of headache episodes were reversible. The characteristic radiologic change was high intensity signal involving the grey matter-white matter junction on the brain diffusion-weighted imaging (DWI), which existed in the frontal lobe and then extended backwards. Atypical features on fluid-attenuated inversion recovery (FLAIR) sequences showing small patchy high signals in the cerebellar vermis. High signals and edema were detected on FLAIR images along the cortex of the left occipito-parieto-temporal lobes, expanding and gradually shrinking in the follow-up visit. Besides, cerebral atrophy and bilateral symmetrical leukoencephalopathy were also detected. Skin biopsy and genetic testing confirmed the diagnosis of NIID. CONCLUSION: Except for typical radiological change strongly suggesting NIID, it is also necessary to notice the insidious symptoms of NIID combining with some atypical imaging features to make an early diagnosis. Skin biopsies or genetic testing should be carried out early in patients with highly suspected NIID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, First Affiliated Hospital of Guangxi Medical University, 530021, Nanning, China.
- Department of Neurology, First Affiliated Hospital of Guangxi Medical University, 530021, Nanning, China. tangyulan7@163.com.
- Department of Neurology, First Affiliated Hospital of Guangxi Medical University, 530021, Nanning, China. luoman@gxmu.edu.cn.
- Guangxi Key Laboratory of Precision Medicine in Cardio-cerebrovascular Diseases Control and Prevention, 530021, Nanning, China. luoman@gxmu.edu.cn.
- Guangxi Clinical Research Center for Cardio-cerebrovascular Diseases, 530021, Nanning, China. luoman@gxmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
- Guangxi Medical and Health Appropriate Technology Development and Application Project
- Guangxi Scholarship Fund of Guangxi Education Department
Zitieren
APA
Wu, X. J., Jiang, Y. Y., Chen, L. J., Zhou, G. Q., Mo, D. C., Liu, L. Y., Li, J. L., Li, X. L., Tang, Y. L., & Luo, M. (2024). Neuronal intranuclear inclusion disease with cortical involvement in left hemisphere: a case report. Wiener klinische Wochenschrift. https://doi.org/10.1007/s00508-023-02232-1
Vancouver
Wu XJ, Jiang YY, Chen LJ, Zhou GQ, Mo DC, Liu LY, et al. Neuronal intranuclear inclusion disease with cortical involvement in left hemisphere: a case report. Wiener klinische Wochenschrift. 2024. doi:10.1007/s00508-023-02232-1
BibTeX
@article{Wu2024,
author = {Wu, Xiao-Ju and Jiang, Yi-Ying and Chen, Li-Jie and Zhou, Guo-Qiu and Mo, Dong-Can and Liu, Liu-Yu and Li, Jian-Li and Li, Xiao-Ling and Tang, Yu-Lan and Luo, Man},
title = {Neuronal intranuclear inclusion disease with cortical involvement in left hemisphere: a case report},
journal = {Wiener klinische Wochenschrift},
year = {2024},
doi = {10.1007/s00508-023-02232-1}
}
EUVIMED